The University of Chicago Header Logo

Connection

Mark Ferguson to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Mark Ferguson has written about Dose-Response Relationship, Drug.
Mark Ferguson
Connection Strength
0.014
Dose-Response Relationship, Drug
  1. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. J Thorac Oncol. 2008 Jan; 3(1):59-67.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.